Fresenius Medical Care AG (FMS)
21.48
+0.93
(+4.53%)
USD |
NYSE |
Apr 23, 16:00
21.46
-0.02
(-0.12%)
Pre-Market: 20:00
Fresenius Medical Care Gross Profit (Quarterly): 1.453B for Dec. 31, 2023
Gross Profit (Quarterly) Chart
Historical Gross Profit (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 1.453B |
September 30, 2023 | 1.338B |
June 30, 2023 | 1.305B |
March 31, 2023 | 1.234B |
December 31, 2022 | 1.258B |
September 30, 2022 | 1.253B |
June 30, 2022 | 1.327B |
March 31, 2022 | 1.317B |
December 31, 2021 | 1.161B |
September 30, 2021 | 1.494B |
June 30, 2021 | 1.547B |
March 31, 2021 | 1.454B |
December 31, 2020 | 1.638B |
September 30, 2020 | 1.589B |
June 30, 2020 | 1.557B |
March 31, 2020 | 1.535B |
December 31, 2019 | 1.610B |
September 30, 2019 | 1.497B |
June 30, 2019 | 1.495B |
March 31, 2019 | 1.437B |
December 31, 2018 | 1.575B |
September 30, 2018 | 1.474B |
June 30, 2018 | 1.557B |
March 31, 2018 | 1.478B |
December 31, 2017 | 1.775B |
Date | Value |
---|---|
September 30, 2017 | 1.674B |
June 30, 2017 | 1.645B |
March 31, 2017 | 1.696B |
December 31, 2016 | 1.676B |
September 30, 2016 | 1.579B |
June 30, 2016 | 1.529B |
March 31, 2016 | 1.428B |
December 31, 2015 | 1.908B |
September 30, 2015 | 1.365B |
June 30, 2015 | 1.278B |
March 31, 2015 | 1.234B |
December 31, 2014 | 1.606B |
September 30, 2014 | 1.345B |
June 30, 2014 | 1.218B |
March 31, 2014 | 1.078B |
December 31, 2013 | 1.204B |
September 30, 2013 | 1.148B |
June 30, 2013 | 1.163B |
March 31, 2013 | 1.144B |
December 31, 2012 | 1.171B |
September 30, 2012 | 1.083B |
June 30, 2012 | 1.143B |
March 31, 2012 | 1.051B |
December 31, 2011 | 1.303B |
September 30, 2011 | 1.103B |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Quarterly) Range, Past 5 Years
1.161B
Minimum
Dec 2021
1.638B
Maximum
Dec 2020
1.424B
Average
1.454B
Median
Mar 2021
Gross Profit (Quarterly) Benchmarks
Biodexa Pharmaceuticals Plc | -- |
NuCana PLC | -- |
Biophytis SA | -- |
TC BioPharm (Holdings) PLC | -- |
DaVita Inc | 1.007B |